Published in Vaccine Weekly, August 16th, 2006
According to recent research from the United States, "Multiple cases of transmission of avian H5N1 influenza viruses to humans illustrate the urgent need for an efficacious, cross-protective vaccine."
"Ferrets were immunized with inactivated whole-virus vaccine produced by reverse genetics with the hemagglutinin (HA) and neuraminidase genes of A/HK/213/03 virus," said Elena A. Govorkova and colleagues at St. Jude Children's Research Hospital. "Ferrets received a single dose of vaccine (7 or 15 mcg of HA) with aluminum...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly